TW234086B - - Google Patents

Info

Publication number
TW234086B
TW234086B TW082102673A TW82102673A TW234086B TW 234086 B TW234086 B TW 234086B TW 082102673 A TW082102673 A TW 082102673A TW 82102673 A TW82102673 A TW 82102673A TW 234086 B TW234086 B TW 234086B
Authority
TW
Taiwan
Application number
TW082102673A
Other languages
Chinese (zh)
Original Assignee
Smithkl Beecham Plc
Smithkline Beecham Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkl Beecham Plc, Smithkline Beecham Lab filed Critical Smithkl Beecham Plc
Application granted granted Critical
Publication of TW234086B publication Critical patent/TW234086B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
TW082102673A 1992-03-27 1993-04-09 TW234086B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9203747A FR2689012A1 (fr) 1992-03-27 1992-03-27 Utilisation de composés aryliques dans le traitement d'affections cardio-vasculaires.

Publications (1)

Publication Number Publication Date
TW234086B true TW234086B (fr) 1994-11-11

Family

ID=9428178

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082102673A TW234086B (fr) 1992-03-27 1993-04-09

Country Status (8)

Country Link
EP (1) EP0632724A1 (fr)
JP (1) JPH07508707A (fr)
KR (1) KR950700736A (fr)
AU (1) AU3764693A (fr)
CA (1) CA2132981A1 (fr)
FR (1) FR2689012A1 (fr)
TW (1) TW234086B (fr)
WO (1) WO1993019754A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8283377B2 (en) 2011-02-15 2012-10-09 China Medical University Method for inhibiting blood vessel stenosis

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753722A1 (fr) * 1996-09-26 1998-03-27 Smithkline Beecham Lab Procede de detection de modulateurs de relaxation cardiaque et modulateurs ainsi obtenus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234186A (en) * 1989-07-07 1991-10-25 Janssen Pharmaceutica Nv Imidazo quinazolin-one derivatives and pharmaceutical compositions
EP0532531A1 (fr) * 1990-05-21 1993-03-24 Smith Kline & French Laboratories Limited Derives de phenol et de pyridinol comme agents pharmaceutiques
EP0550576A1 (fr) * 1990-09-28 1993-07-14 Smith Kline & French Laboratories Limited Derives de phenylpyridinol utilises comme medicaments

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8283377B2 (en) 2011-02-15 2012-10-09 China Medical University Method for inhibiting blood vessel stenosis

Also Published As

Publication number Publication date
AU3764693A (en) 1993-11-08
CA2132981A1 (fr) 1993-10-14
KR950700736A (ko) 1995-02-20
JPH07508707A (ja) 1995-09-28
EP0632724A1 (fr) 1995-01-11
WO1993019754A1 (fr) 1993-10-14
FR2689012A1 (fr) 1993-10-01

Similar Documents

Publication Publication Date Title
TW227644B (fr)
DE9206638U1 (fr)
DE9200236U1 (fr)
DE9200124U1 (fr)
DE9201546U1 (fr)
DE9209544U1 (fr)
DE9200121U1 (fr)
DE9206173U1 (fr)
DE9200172U1 (fr)
TW234086B (fr)
DE9200188U1 (fr)
DE9200256U1 (fr)
DE9200230U1 (fr)
DE9203035U1 (fr)
DE9200294U1 (fr)
DE9207542U1 (fr)
DE9210758U1 (fr)
DE9215357U1 (fr)
DE9308504U1 (fr)
DE9200305U1 (fr)
DE9206699U1 (fr)
DE9200293U1 (fr)
DE9200211U1 (fr)
DE9200221U1 (fr)
DE9200129U1 (fr)